Skip to main content

Table 2 Median BLL across the users groups

From: Lead poisoning among opium users in Iran: an emerging health hazard

Type of substance

Route of use

Blood lead level a (μg/dL)

Median [IQR]

Minimum

Maximum

X 2

p-value

Opium (taryak)

Smoking (n = 12)

80.0 [45.7–110.0]

36.0

126.0

0.17

0.92

Oral route (n = 154)

80.0 [51.7–120.0]

26

350

Smoking + oral route (n = 43)

85.0 [51.0–116.0]

30

235

Refined opium (shireh)

Smoking (n = 5)

96.5 [19.7–143.2]

70

150

2.37

0.31

Oral route (n = 10)

140.0 [66.5–170.5]

58

250

Smoking + oral route (n = 1)

55.7 [55.7–55.7]

55.7

55.7

Opium (Taryak) + refined opium

Smoking (n = 4)

48.3 [39.0–56.4]

39

58

2.51

0.28

Oral route (n = 16)

72.1 [38.2–88.7]

27

200

Smoking + oral route (n = 4)

90.0 [54.8–156.5]

52

205

Total

Smoking (n = 21)

70 [39.8–110.0]

36

150

 

Oral route (n = 180)

80.0 [51.2–120.7]

26

350

Smoking + oral route (n = 48)

85.0 [52.4–113.0]

30

235

  1. Median blood lead level (BLL) differences between routes of administration (smoking, oral and combination users) across the user groups (raw opium; refined opium; and combination users)
  2. a compared using Kruskal Wallis test
  3. Degrees of freedom for BLL (df = 2)